filmov
tv
Trialing Outpatient Treatments for Moderate COVID Cases | COVID-19 Media Briefing
Показать описание
A new study led by the Duke Clinical Research Institute is looking at whether three existing medications would treat mild-to-moderate COVID-19 effectively. (More information on the study is available here.)
The three repurposed medications, already approved by the U.S. Food and Drug Administration for other uses, are:
- Ivermectin, used to treat parasitic infections;
- Fluticasone, an inhaled steroid commonly prescribed for asthma and chronic obstructive pulmonary disease; and
- Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), often prescribed for depression.
On Tuesday, institute executive director Adrian Hernandez discussed the study with reporters in a virtual media briefing, where he touched on the need for COVID-19 therapies and making it easy for people across the country to take part in the study.
𝐓𝐡𝐞 𝐏𝐚𝐧𝐞𝐥𝐢𝐬𝐭
Adrian Hernandez, M.D., is a cardiologist, vice dean of the Duke University School of Medicine and executive director of the Duke Clinical Research Institute, where he oversees clinical research programs, clinical trials and clinical education.
𝐌𝐞𝐝𝐢𝐚 𝐁𝐫𝐢𝐞𝐟𝐢𝐧𝐠𝐬
This video is part of a series of media briefings where Duke experts speak on current issues.
𝐀𝐛𝐨𝐮𝐭 𝐃𝐮𝐤𝐞 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲
A private research university located in Durham, North Carolina, Duke University is known as one of the world’s leading institutions for education, research, and patient care.
𝐅𝐨𝐥𝐥𝐨𝐰 #𝐃𝐮𝐤𝐞𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲
The three repurposed medications, already approved by the U.S. Food and Drug Administration for other uses, are:
- Ivermectin, used to treat parasitic infections;
- Fluticasone, an inhaled steroid commonly prescribed for asthma and chronic obstructive pulmonary disease; and
- Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), often prescribed for depression.
On Tuesday, institute executive director Adrian Hernandez discussed the study with reporters in a virtual media briefing, where he touched on the need for COVID-19 therapies and making it easy for people across the country to take part in the study.
𝐓𝐡𝐞 𝐏𝐚𝐧𝐞𝐥𝐢𝐬𝐭
Adrian Hernandez, M.D., is a cardiologist, vice dean of the Duke University School of Medicine and executive director of the Duke Clinical Research Institute, where he oversees clinical research programs, clinical trials and clinical education.
𝐌𝐞𝐝𝐢𝐚 𝐁𝐫𝐢𝐞𝐟𝐢𝐧𝐠𝐬
This video is part of a series of media briefings where Duke experts speak on current issues.
𝐀𝐛𝐨𝐮𝐭 𝐃𝐮𝐤𝐞 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲
A private research university located in Durham, North Carolina, Duke University is known as one of the world’s leading institutions for education, research, and patient care.
𝐅𝐨𝐥𝐥𝐨𝐰 #𝐃𝐮𝐤𝐞𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲
0:19:57
Trialing Outpatient Treatments for Moderate COVID Cases | COVID-19 Media Briefing
0:16:12
Best Practices for Outpatient CAR-T Therapy
0:03:28
Outpatient COVID-19 Recovery & Rehab Services with Dr. Jerry Kaplan
0:06:28
Got COVID? Watch this for outpatient treatment options available in 2022
0:59:04
Stratified treatment of INOCA: from the cathlab to the outpatient clinic - Webinar
1:37:39
JJ 20 Outpatient Medications for COVID-19
1:24:20
Intensive Outpatient Treatment of Substance Use Disorders
0:57:40
Outpatient Management of CHF in 2019: Beyond ACE Inhibition
0:10:15
Day 2 ~ 💊💊COVID Outpatient Care & Drug-drug Interactions Webinar 💊💊
1:27:10
COVID-19 Outpatient Management: Insights, Treatments and Challenges
1:55:18
Early Outpatient Treatment in Practice
1:08:32
Assisted Outpatient Treatment (AOT): Promising Practices: An Overview
0:08:36
CAR T-Cell Therapy as an Outpatient Treatment Option
0:02:47
Convalescent plasma to treat outpatient Covid 19 - Judith Currier, MD | UCLA Health Clinical Trials
1:01:33
Antibiotic Stewardship in the outpatient setting: now less is Better with Dr. Jacobson-May 10, 2023
1:14:28
Difficult Cases in Prevention and Outpatient Care for COVID-19
0:10:19
Module 6: Practical Consideration | Outpatient Management by Sophia Tapper
0:24:57
Ivermectin not effective for Covid-19 progression: I-TECH clinical trial results
0:47:23
Outpatient Procedural Sedation by the Pediatric Intensivist by P. Kamat | OPENPediatrics
1:00:18
COVID-19 Treatment Across the Clinical Spectrum: Outpatient Treatment
0:14:58
Outpatient 3: Post Acute Care Issues by Lauren Mellett
1:01:39
Up to the Minute in Clinical Care: Outpatient Rehabilitation Care for Concussion
0:04:47
Outpatient clinical trials with the goal of finding effective early treatments for COVID-19 using ex
0:59:17
Updates in outpatient medicine
Комментарии